Clinical trial
Long-Term Safety Follow-Up Study of Psoriasis Patients Who Have Received MEDI-507
NCT00131066 is registered in ClinicalTrials.gov with MedImmune LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long-Term Safety Follow-Up Study of Psoriasis Patients Who Have Received MEDI-507
- Lead sponsor
- MedImmune LLC
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 31, 2002
- Completion date
- December 31, 2007
- Enrollment
- 200 (actual)
- Sites
- 21
Conditions
As the registry lists them; a condition with its own page is linked.